Back to search
FDAFDA · Food and drugs·Recall number Z-2631-2024

Medline procedure packs containing Shenli syringes, labeled as follows: 1) CVC DOUBLE LUMEN 16CM, Pack Number ECVC8105; 2) VANTEX 7FR 3L 20CM CVC BUNDLE US, Pack Number ECVC8045

Published September 4, 2024 · Recall initiated: April 8, 2024

Summary

FDA records medical device Class II recall Z-2631-2024, published September 4, 2024 and initiated April 8, 2024. Recalling firm: MEDLINE INDUSTRIES, LP - Northfield; Status: Ongoing; Reported quantity: 1,679,067 units in total; Lot: ECVC8105, Lot Number 2023052690; ECVC8105, Lot Number 2023100490; ECVC8045, Lot Number 2023110990. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Medical convenience kits contain plastic syringes affected by the FDA Safety Alert issued on March 19, 2024. Leaks, breakage, and/ other quality issues have been identified that may pose a risk to patient health.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
MEDLINE INDUSTRIES, LP - Northfield
Distributor
Worldwide distribution.
Lot
ECVC8105, Lot Number 2023052690; ECVC8105, Lot Number 2023100490; ECVC8045, Lot Number 2023110990
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Medline procedure packs containing Shenli syringes, labeled as follows: 1) CVC DOUBLE LUMEN 16CM, Pack Number ECVC8105; 2) VANTEX 7FR 3L 20CM CVC BUNDLE US, Pack Number ECVC8045 recalled?

Yes. FDA published recall Z-2631-2024 on September 4, 2024. Reported hazard: Medical convenience kits contain plastic syringes affected by the FDA Safety Alert issued on March 19, 2024. Leaks, breakage, and/ other quality issues have been identified that may pose a risk to patient health.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit